Login to Your Account

BIO CEO Investor Conference

Follow-on Biologics Law Called Key Issue for Biotech this Year

By Donna Young

Tuesday, February 12, 2008
The most important issue facing the biotechnology industry last year - and again in the coming year - is legislation governing follow-on biologics, said Nick Littlefield, partner and chairman of the government strategies group at the Boston law firm Foley Hoag LLP. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription